Off-Label Practices Plague Circulatory System Device Randomized Trials
This article was originally published in The Gray Sheet
Executive Summary
Off-label use of biliary stents is hindering superficial femoral artery (SFA) device development, CDRH Division of Cardiovascular Devices Director Bram Zuckerman told participants at CRT 2004 in Washington, D.C